Summary
GB24 is a mouse monoclonal antibody raised against a common trophoblast-lymphocyte cross-reactive antigen. GB24 detects the membrane cofactor protein (MCP, CD46), a member of the complement regulatory protein family, which serves as a cofactor for factor 1 mediated cleavage of C3b. This study investigated the reactivity of GB24 on 38 breast carcinomas and 34 normal/benign breast tissues by immunochemistry as well as the reactivity of F2B7-2, an antibody specific to the decay accelerating factor (DAF, CD55) of the complement. GB24 staining was present on both normal tissue and benign lesions, but very strong diffuse reactivity was observed on carcinomas. This reactivity increased with the tumor grade. By contrast, malignant tumor cells lacked DAF expression. F2B7-2 antibody reacted weakly with benign epithelial cells. Results were studied by computer assisted image analysis to accurately define the mean optical densities. The densitometric analysis of MCP positive carcinomas showed a high intensity of the staining. Expression of MCP and DAF on MCF-7 cell lines was analyzed by flow cytometry. MCF-7 cell lines were strongly stained by mAb GB24 only. These data suggest that selectively enhanced expression of the antigen recognized by GB24 is associated with malignant breast disorders. This high expression, which may reflect a protective mechanism by which tumor cells survive complement activation, may prove useful as a marker of malignant transformation.
This is a preview of subscription content, log in via an institution to check access.
References
Fleming KA, McMichael A, Morton JA, Woods J, McGee JOD: Distribution of HLA class I antigens in normal human tissue and in mammary cancer. J Clin Pathol 34: 779–784, 1981
Hsi BL, Yeh CJG, Stevens PJ, Faulk WP: Transferrin receptors, HLA and amniotic epithelial antigens in breast adenocarcinoma. Protides of the Biological Fluids 32: 591–584, 1984
Faulk WP, Hsi BL, Stevens PJ: Transferrin and transferrin receptors in carcinoma of the human breast. Lancet ii: 390–392, 1980
Vogel CW: Complement, a biologic effector mechanism for tumor cell killing. Immunology and Allergy Clinics of North America 11: 277–299, 1991
Seya T, Atkinson JP: Functional properties of membrane cofactor protein of complement. Biochem J 264: 581–588, 1989
Atkinson JP, Farries T: Separation of self from non-self in the complement system. Immunol Today 8: 212–215, 1987
Hsi BL, Fenichel P, Milesi-Fluet C, Cervoni F: Expression of complement regulatory proteins on human gametes and trophoblast. In: Chaouat G, Mowbray J (eds) Cellular and Molecular Biology of the Materno-fetal Relationship. Colloque INSERM, John Libbey Eurotext Ltd, 1991, 212, pp 3–11
Seya T, Hara T, Matsumoto M, Akeda H: Quantitative analysis of membrane cofactor protein (MCP) of complement. High expression of MCP on human leukemia cell lines which is down regulated during cell differentiation. J Immunol 145: 238–245, 1990
Milesi-Fluet C, Adams EM, Cervoni F, Atkinson JP, Hsi BL: The expression of complement regulatory proteins on human choriocarcinoma cell lines JEG-3 and JAR. J Immunol Immunopharmacol 12: 120, 1992 (abstract)
Hsi BL, Yeh CJG: Monoclonal antibody GB25 recognizes human villous trophoblasts. Am J Reprod Immunol Microbiol 12: 1–3, 1986
Yeh CJG, Hsi BL: The expression of epithelial antigens by trophoblasts and tumor cells using monoclonal antibodies to human amnion (GB3 and GB5). Trophoblast Res 2: 215–222, 1987
Hsi BL, Yeh CJG, Fenichel P: Monoclonal antibody GB24 recognizes a trophoblast-lymphocyte cross-reactive antigen. Am J Reprod Immunol Microbiol 18: 21–27, 1988
Cho SW, Oglesby TS, Hsi BL: Characterization of three monoclonal antibodies to membrane cofactor protein (MCP) of the complement system and quantification of MCP by radioimmunoassay. Clin Exp Immunol 83: 257–261, 1991
Elston CW: Grading of invasive carcinomas of the breast. In: Page DL, Anderson TJ (eds) Diagnostic Histopathology of the Breast. Churchill Livingstone Edinburgh, 1987, pp 300–311
Royal College of Pathologists Working Group: Pathology Reporting in Breast Cancer Screening. Oxford, UK, Screening Publications, 1990, pp 26–27
Hadam MR: Cluster report: CD55. In: Knapp W (ed) Leukocyte typing IV: white cell differentiation antigens. Oxford University Press, 1989, p 694
McNearney T, Ballard L, Seya T, Atkinson JP: Membrane cofactor protein of complement is present on human fibroblast, epithelial and endothelial cells. J Clin Invest 84: 538–545, 1989
Medof ME, Walter EI, Rutgers JL, Knowles DM, Nussenweig V: Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids. J Exp Med 165: 848–864, 1987
Liszewski MK, Post TW, Atkinson JP: Membrane cofactor protein (MCP or CD46): Newest member of the regulators of complement activation gene cluster. Ann Rev Immunol 9: 431–455, 1991
Seya T, Hara T, Matsumoto M, Sugita Y, Akedo H: Complement-mediated tumor cell damage induced by antibodies against membrane cofactor protein (MCP, CD46). J Exp Med 172: 1673–1680, 1990
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hofman, P., Hsi, B.L., Manie, S. et al. High expression of the antigen recognized by the monoclonal antibody GB24 on human breast carcinomas: A preventive mechanism of malignant tumor cells against complement attack?. Breast Cancer Res Tr 32, 213–219 (1994). https://doi.org/10.1007/BF00665772
Issue Date:
DOI: https://doi.org/10.1007/BF00665772